Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

European Huntington's Disease Network, Huntington Study Group investigators

Research output: Contribution to journal › Article › peer-review

79 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science